Duopharma to supply 6.4 million doses of Sputnix V vaccine 


KUALA LUMPUR: Duopharma Biotech Bhd has entered into a deal to supply the Ministry of Health with 6.4 million doses of Covid-19 vaccine developed by Russia.

The supply is subject to the “Sputnik V” vaccine being approved by Drug Control Authority, Malaysia through technical evaluation by the National Pharmaceutical Regulatory Agency.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Duopharma Biotech , vaccine , Sputnix V

   

Next In Business News

Sabah's Life Water rises 18.46% on Main Market debut
Ringgit opens marginally higher against US$ ahead of upcoming inflation data
Bursa Malaysia remains on a slide as US rally takes breather
Trading ideas: Maybank, Capital A, Sapura Energy, Paragon, Atlan, Fajarbaru, Tiong Nam, T7, Carimin, Jati Tinggi, MCE, Heineken
Oil ends lower after Opec cuts demand view
Mida identifies 12 Egyptian companies interested in investing in Malaysia - Tengku Zafrul
Kerjaya set to gain from JV with Aspen
Singapore project to lift Sunway’s 3Q24 earnings
Maybank weighing options for insurer Etiqa
Guocoland braces for challenges

Others Also Read